We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+12.16%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$718B
AUM Growth
+$49.7B
Cap. Flow
-$15.6B
Cap. Flow %
-2.17%
Top 10 Hldgs %
31.75%
Holding
3,044
New
123
Increased
1,636
Reduced
968
Closed
150

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.11B
2
META icon
Meta Platforms (Facebook)
META
+$2.59B
3
EQT icon
EQT Corp
EQT
+$1.31B
4
CL icon
Colgate-Palmolive
CL
+$1.08B
5
ADBE icon
Adobe
ADBE
+$1.06B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.92B
2
UNH icon
UnitedHealth
UNH
+$1.78B
3
AMD icon
Advanced Micro Devices
AMD
+$1.55B
4
ROST icon
Ross Stores
ROST
+$1.54B
5
ASML icon
ASML
ASML
+$1.49B

Sector Composition

Rank Sector Weight
1 Technology 31.61%
2 Healthcare 16.91%
3 Consumer Discretionary 11.05%
4 Financials 10.6%
5 Communication Services 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSPN icon
2001
OneSpan
OSPN
$609M
$657K ﹤0.01%
44,247
+13,473
+44% +$210K
FLNA
2002
Filana Therapeutics
FLNA
$45.1M
$656K ﹤0.01%
26,719
-248
-0.9% -$5.97K
ETD icon
2003
Ethan Allen Interiors
ETD
$575M
$654K ﹤0.01%
23,120
+77
+0.3% +$2.09K
IRWD icon
2004
Ironwood Pharmaceuticals
IRWD
$714M
$653K ﹤0.01%
61,345
+1,551
+3% +$16.7K
DGRO icon
2005
iShares Core Dividend Growth ETF
DGRO
$43.9B
$652K ﹤0.01%
12,639
AUR icon
2006
Aurora
AUR
$13.4B
$650K ﹤0.01%
221,027
+61,630
+39% +$103K
NNI icon
2007
Nelnet
NNI
$4.52B
$650K ﹤0.01%
6,732
+3,915
+139% +$372K
UEC icon
2008
Uranium Energy
UEC
$5.62B
$648K ﹤0.01%
190,332
+15,221
+9% +$43.4K
NSSC icon
2009
Napco Security Technologies
NSSC
$1.39B
$647K ﹤0.01%
18,657
-1,169
-6% -$40.8K
HIMS icon
2010
Hims & Hers Health
HIMS
$6.71B
$645K ﹤0.01%
68,532
-28,489
-29% -$282K
NMRK icon
2011
Newmark Group
NMRK
$2.68B
$644K ﹤0.01%
103,488
+5,459
+6% +$33.6K
DMC
2012
Del Monte Corp
DMC
$1.42B
$643K ﹤0.01%
25,000
+1,139
+5% +$31.4K
SBH icon
2013
Sally Beauty Holdings
SBH
$1.55B
$640K ﹤0.01%
51,745
+1,276
+3% +$16.2K
UTZ icon
2014
Utz Brands
UTZ
$1.25B
$640K ﹤0.01%
39,089
+5,935
+18% +$102K
RWT
2015
Redwood Trust
RWT
$592M
$639K ﹤0.01%
100,209
+1,043
+1% +$6.51K
TRC icon
2016
Tejon Ranch
TRC
$441M
$638K ﹤0.01%
37,061
+5,375
+17% +$93.4K
AROW icon
2017
Arrow Financial
AROW
$723M
$637K ﹤0.01%
32,558
+6,908
+27% +$141K
ECHO
2018
EchoStar
ECHO
$26.6B
$634K ﹤0.01%
36,471
+1,226
+3% +$20.6K
OM icon
2019
Outset Medical
OM
$84.6M
$632K ﹤0.01%
1,924
+574
+43% +$175K
ERII icon
2020
Energy Recovery
ERII
$397M
$631K ﹤0.01%
22,546
+769
+4% +$19.2K
IBTX
2021
DELISTED
Independent Bank Group, Inc.
IBTX
$629K ﹤0.01%
18,195
+413
+2% +$15.3K
AORT icon
2022
Artivion
AORT
$1.39B
$627K ﹤0.01%
36,464
+566
+2% +$8.34K
WTBA icon
2023
West Bancorporation
WTBA
$503M
$625K ﹤0.01%
33,916
+1,752
+5% +$30.5K
XPER icon
2024
Xperi
XPER
$321M
$625K ﹤0.01%
47,466
+3,523
+8% +$38.2K
CCSI icon
2025
Consensus Cloud Solutions
CCSI
$695M
$619K ﹤0.01%
19,942
-110,127
-85% -$3.88M

Similar funds

T. Rowe Price Associates's Q2 2023 Portfolio in Review

As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
  • T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
  • T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
  • T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
  • T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
  • T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.